AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
BEVACIZUMAB in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ABEVMY - 100 INJECTABLE; INJECTION | 2021/9.7/6140 | BIOSIMILARS NEWCO LIMITED | active | 31 Dec 2027 |
| AVASTIN ® 100 INJECTABLE; INJECTION | 2016/9.7/5262 | ROCHE PRODUCTS (PTY) LTD | active | 31 Dec 2027 |
| ABEVMY - 400 INJECTABLE; INJECTION | 2021/9.7/6141 | BIOSIMILARS NEWCO LIMITED | active | 31 Dec 2027 |
| AVASTIN ® 400 INJECTABLE; INJECTION | 2016/9.7/5263 | ROCHE PRODUCTS (PTY) LTD | active | 31 Dec 2027 |
BEVACIZUMAB — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing BEVACIZUMAB, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track BEVACIZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.